Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer

Stefano Mattarocci, Claudia Abbruzzese, Anna M. Mileo, Paolo Visca, Barbara Antoniani, Gabriele Alessandrini, Francesco Facciolo, Armando Felsani, Razvan T. Radulescu, Marco G. Paggi

Research output: Contribution to journalArticle

Abstract

Insulin has been known for a long time to influence the growth and differentiation of normal and transformed cells. In order to delineate the role of insulin specifically in non-small cell lung cancer (NSCLC), we have now searched by immunohistochemistry (IHC) for the presence of insulin in NSCLC samples. Among the 112 samples we studied, 30 were found to contain insulin, which was detected in the form of intracytoplasmic granula. Moreover, its expression significantly correlated with (a) the morphological/histopathological subtype of NSCLC, being more frequent in adenocarcinomas; (b) the grade of tumor differentiation, displaying an increase in low-grade carcinomas; (c) tumor size, occurring predominantly in smaller tumors; (d) the presence of phosphorylated, activated insulin receptor; (e) the median patient age, being present in relatively younger individuals. Furthermore and interestingly, surrounding atypical adenomatous hyperplastic areas and normal alveolar pneumocytes scored insulin-positive in some of the insulin-negative tumors. In addition, PCR exploration for insulin transcripts in some samples positive for immunoreactive insulin was negative, indicating a possibly exogenous origin for the intracellular insulin in our NSCLC cohort. Taken together, our data suggest that an intracellular insulin activity is important for the progression of low-grade human lung adenocarcinomas.

Original languageEnglish
Pages (from-to)766-770
Number of pages5
JournalJournal of Cellular Physiology
Volume221
Issue number3
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Non-Small Cell Lung Carcinoma
Cells
Insulin
Tumors
Neoplasms
Alveolar Epithelial Cells
Insulin Receptor
Adenocarcinoma
Immunohistochemistry
Carcinoma
Polymerase Chain Reaction
Growth

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer. / Mattarocci, Stefano; Abbruzzese, Claudia; Mileo, Anna M.; Visca, Paolo; Antoniani, Barbara; Alessandrini, Gabriele; Facciolo, Francesco; Felsani, Armando; Radulescu, Razvan T.; Paggi, Marco G.

In: Journal of Cellular Physiology, Vol. 221, No. 3, 12.2009, p. 766-770.

Research output: Contribution to journalArticle

Mattarocci, Stefano ; Abbruzzese, Claudia ; Mileo, Anna M. ; Visca, Paolo ; Antoniani, Barbara ; Alessandrini, Gabriele ; Facciolo, Francesco ; Felsani, Armando ; Radulescu, Razvan T. ; Paggi, Marco G. / Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer. In: Journal of Cellular Physiology. 2009 ; Vol. 221, No. 3. pp. 766-770.
@article{31971654d8824b66b94cd6b0a8a1535a,
title = "Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer",
abstract = "Insulin has been known for a long time to influence the growth and differentiation of normal and transformed cells. In order to delineate the role of insulin specifically in non-small cell lung cancer (NSCLC), we have now searched by immunohistochemistry (IHC) for the presence of insulin in NSCLC samples. Among the 112 samples we studied, 30 were found to contain insulin, which was detected in the form of intracytoplasmic granula. Moreover, its expression significantly correlated with (a) the morphological/histopathological subtype of NSCLC, being more frequent in adenocarcinomas; (b) the grade of tumor differentiation, displaying an increase in low-grade carcinomas; (c) tumor size, occurring predominantly in smaller tumors; (d) the presence of phosphorylated, activated insulin receptor; (e) the median patient age, being present in relatively younger individuals. Furthermore and interestingly, surrounding atypical adenomatous hyperplastic areas and normal alveolar pneumocytes scored insulin-positive in some of the insulin-negative tumors. In addition, PCR exploration for insulin transcripts in some samples positive for immunoreactive insulin was negative, indicating a possibly exogenous origin for the intracellular insulin in our NSCLC cohort. Taken together, our data suggest that an intracellular insulin activity is important for the progression of low-grade human lung adenocarcinomas.",
author = "Stefano Mattarocci and Claudia Abbruzzese and Mileo, {Anna M.} and Paolo Visca and Barbara Antoniani and Gabriele Alessandrini and Francesco Facciolo and Armando Felsani and Radulescu, {Razvan T.} and Paggi, {Marco G.}",
year = "2009",
month = "12",
doi = "10.1002/jcp.21916",
language = "English",
volume = "221",
pages = "766--770",
journal = "Journal of cellular and comparative physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer

AU - Mattarocci, Stefano

AU - Abbruzzese, Claudia

AU - Mileo, Anna M.

AU - Visca, Paolo

AU - Antoniani, Barbara

AU - Alessandrini, Gabriele

AU - Facciolo, Francesco

AU - Felsani, Armando

AU - Radulescu, Razvan T.

AU - Paggi, Marco G.

PY - 2009/12

Y1 - 2009/12

N2 - Insulin has been known for a long time to influence the growth and differentiation of normal and transformed cells. In order to delineate the role of insulin specifically in non-small cell lung cancer (NSCLC), we have now searched by immunohistochemistry (IHC) for the presence of insulin in NSCLC samples. Among the 112 samples we studied, 30 were found to contain insulin, which was detected in the form of intracytoplasmic granula. Moreover, its expression significantly correlated with (a) the morphological/histopathological subtype of NSCLC, being more frequent in adenocarcinomas; (b) the grade of tumor differentiation, displaying an increase in low-grade carcinomas; (c) tumor size, occurring predominantly in smaller tumors; (d) the presence of phosphorylated, activated insulin receptor; (e) the median patient age, being present in relatively younger individuals. Furthermore and interestingly, surrounding atypical adenomatous hyperplastic areas and normal alveolar pneumocytes scored insulin-positive in some of the insulin-negative tumors. In addition, PCR exploration for insulin transcripts in some samples positive for immunoreactive insulin was negative, indicating a possibly exogenous origin for the intracellular insulin in our NSCLC cohort. Taken together, our data suggest that an intracellular insulin activity is important for the progression of low-grade human lung adenocarcinomas.

AB - Insulin has been known for a long time to influence the growth and differentiation of normal and transformed cells. In order to delineate the role of insulin specifically in non-small cell lung cancer (NSCLC), we have now searched by immunohistochemistry (IHC) for the presence of insulin in NSCLC samples. Among the 112 samples we studied, 30 were found to contain insulin, which was detected in the form of intracytoplasmic granula. Moreover, its expression significantly correlated with (a) the morphological/histopathological subtype of NSCLC, being more frequent in adenocarcinomas; (b) the grade of tumor differentiation, displaying an increase in low-grade carcinomas; (c) tumor size, occurring predominantly in smaller tumors; (d) the presence of phosphorylated, activated insulin receptor; (e) the median patient age, being present in relatively younger individuals. Furthermore and interestingly, surrounding atypical adenomatous hyperplastic areas and normal alveolar pneumocytes scored insulin-positive in some of the insulin-negative tumors. In addition, PCR exploration for insulin transcripts in some samples positive for immunoreactive insulin was negative, indicating a possibly exogenous origin for the intracellular insulin in our NSCLC cohort. Taken together, our data suggest that an intracellular insulin activity is important for the progression of low-grade human lung adenocarcinomas.

UR - http://www.scopus.com/inward/record.url?scp=70449699792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449699792&partnerID=8YFLogxK

U2 - 10.1002/jcp.21916

DO - 10.1002/jcp.21916

M3 - Article

C2 - 19688775

AN - SCOPUS:70449699792

VL - 221

SP - 766

EP - 770

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

IS - 3

ER -